{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:59Z","timestamp":1786120259255,"version":"build-2736575974"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/icu.0b013e32835cfe92","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T08:55:00Z","timestamp":1357203300000},"page":"130-135","source":"Crossref","is-referenced-by-count":24,"title":["Nanotechnology and glaucoma"],"prefix":"10.1097","volume":"24","author":[{"given":"Daniel W.","family":"Pita-Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210206","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020.","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R2-8-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000081775","article-title":"Diabetes mellitus as a risk factor for glaucomatous optic neuropathy.","volume":"219","author":"Nakamura","year":"2005","journal-title":"Ophthalmologica"},{"key":"R3-8-20210206","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00061198-200404000-00003","article-title":"Risk factors for elevated intraocular pressure in uveitis.","volume":"13","author":"Herbert","year":"2004","journal-title":"J Glaucoma"},{"key":"R4-8-20210206","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ophtha.2011.11.003","article-title":"Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement.","volume":"119","author":"Chang","year":"2012","journal-title":"Ophthalmology"},{"key":"R5-8-20210206","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","article-title":"Primary open-angle glaucoma.","volume":"363","author":"Weinreb","year":"2004","journal-title":"Lancet"},{"key":"R6-8-20210206","doi-asserted-by":"crossref","first-page":"e21967","DOI":"10.1371\/journal.pone.0021967","article-title":"Genome-wide linkage scan for primary open angle glaucoma: influences of ancestry and age at diagnosis.","volume":"6","author":"Crooks","year":"2011","journal-title":"PLoS One"},{"key":"R7-8-20210206","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1073\/pnas.0907564106","article-title":"Common variants on chromosome 2 and risk of primary open-angle glaucoma in the Afro-Caribbean population of Barbados.","volume":"106","author":"Jiao","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R8-8-20210206","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1442-9071.2002.00519.x","article-title":"Relationship between age and intraocular pressure: the Blue Mountains Eye Study.","volume":"30","author":"Rochtchina","year":"2002","journal-title":"Clin Exp Ophthalmol"},{"key":"R9-8-20210206","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1167\/iovs.08-2822","article-title":"Y, Foster P J, et al. The relationship of intraocular pressure with age, systolic blood pressure, and central corneal thickness in an Asian population.","volume":"50","author":"Wong","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-8-20210206","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.ophtha.2010.01.035","article-title":"Ocular biometry and open-angle glaucoma: the Los Angeles Latino Eye Study.","volume":"117","author":"Kuzin","year":"2010","journal-title":"Ophthalmology"},{"key":"R11-8-20210206","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00061198-200408000-00010","article-title":"Open-angle glaucoma and systemic hypertension: the Blue Mountains Eye Study.","volume":"13","author":"Mitchell","year":"2004","journal-title":"J Glaucoma"},{"key":"R12-8-20210206","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ophtha.2007.03.017","article-title":"Risk factors for incident open-angle glaucoma: the Barbados Eye Studies.","volume":"115","author":"Leske","year":"2008","journal-title":"Ophthalmology"},{"key":"R13-8-20210206","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/IJG.0b013e31815a343b","article-title":"Premise and prediction-how optic nerve head biomechanics underlies the susceptibility and clinical behavior of the aged optic nerve head.","volume":"17","author":"Burgoyne","year":"2008","journal-title":"J Glaucoma"},{"key":"R14-8-20210206","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/eye.2011.97","article-title":"Primary open-angle glaucoma genes.","volume":"25","author":"Fingert","year":"2011","journal-title":"Eye (Lond)"},{"key":"R15-8-20210206","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.exer.2008.08.011","article-title":"Glaucoma-associated myocilin: a better understanding but much more to learn.","volume":"88","author":"Resch","year":"2009","journal-title":"Exp Eye Res"},{"key":"R16-8-20210206","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1093\/hmg\/ddq146","article-title":"Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice.","volume":"19","author":"Chi","year":"2010","journal-title":"Hum Mol Genet"},{"key":"R17-8-20210206","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1442-9071.2010.02455.x","article-title":"Vascular risk factors in glaucoma: a review.","volume":"39","author":"Yanagi","year":"2011","journal-title":"Clin Exp Ophthalmol"},{"key":"R19-8-20210206","first-page":"487","article-title":"Collaborative Normal-Tension Glaucoma Study Group.","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"R20-8-20210206","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ophtha.2005.10.034","article-title":"Patient-reported behavior and problems in using glaucoma medications.","volume":"113","author":"Sleath","year":"2006","journal-title":"Ophthalmology"},{"key":"R21-8-20210206","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/PPA.S23780","article-title":"Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review.","volume":"5","author":"Reardon","year":"2011","journal-title":"Patient Prefer Adherence"},{"key":"R22-8-20210206","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2105\/AJPH.83.5.711","article-title":"Treatment for glaucoma: adherence by the elderly.","volume":"83","author":"Gurwitz","year":"1993","journal-title":"Am J Public Health"},{"key":"R23-8-20210206","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ajo.2005.04.051","article-title":"Persistence and adherence with topical glaucoma therapy.","volume":"140","author":"Nordstrom","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R24-8-20210206","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejps.2012.05.007","article-title":"Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes.","volume":"47","author":"Loch","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"R25-8-20210206","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0731-7085(97)00060-5","article-title":"Evaluation of microdialysis sampling of aqueous humor for in vivo models of ocular absorption and disposition.","volume":"16","author":"Rittenhouse","year":"1998","journal-title":"J Pharm Biomed Anal"},{"key":"R26-8-20210206","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-3659(02)00175-X","article-title":"Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies.","volume":"83","author":"Wei","year":"2002","journal-title":"J Control Release"},{"key":"R27-8-20210206","first-page":"627","article-title":"Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.","volume":"38","author":"Hamalainen","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R28-8-20210206","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/eye.2011.82","article-title":"Novel drug delivery systems for glaucoma.","volume":"25","author":"Lavik","year":"2011","journal-title":"Eye (Lond)"},{"key":"R29-8-20210206","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/bmc.529","article-title":"Pharmacokinetics of timolol in aqueous humor sampled by microdialysis after topical administration of thermosetting gels.","volume":"20","author":"Wei","year":"2006","journal-title":"Biomed Chromatogr"},{"key":"R31-8-20210206","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ajo.2010.09.026","article-title":"A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.","volume":"151","author":"Krupin","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R32-8-20210206","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/ICU.0b013e32834ff490","article-title":"Clinical trials for glaucoma neuroprotection are not impossible.","volume":"23","author":"Quigley","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"key":"R33-8-20210206","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1076\/ceyr.18.2.91.5381","article-title":"Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs.","volume":"18","author":"Acheampong","year":"1999","journal-title":"Curr Eye Res"},{"key":"R34-8-20210206","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration.","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"R35-8-20210206","doi-asserted-by":"crossref","first-page":"e37543","DOI":"10.1371\/journal.pone.0037543","article-title":"Poly(beta-amino ester)-nanoparticle mediated transfection of retinal pigment epithelial cells in vitro and in vivo.","volume":"7","author":"Sunshine","year":"2012","journal-title":"PLoS One"},{"key":"R37-8-20210206","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4155\/tde.11.20","article-title":"Polymeric vectors for ocular gene delivery.","volume":"2","author":"Tamboli","year":"2011","journal-title":"Ther Deliv"},{"key":"R39-8-20210206","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/nnano.2006.91","article-title":"Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides.","volume":"1","author":"Chen","year":"2006","journal-title":"Nat Nanotechnol"},{"key":"R40-8-20210206","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0169-409X(95)00026-4","article-title":"The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.","volume":"19","author":"Gref","year":"1995","journal-title":"Adv Drug Deliv Rev"},{"key":"R42-8-20210206","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2217\/nnm.11.11","article-title":"Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.","volume":"6","author":"Tosi","year":"2011","journal-title":"Nanomed"},{"key":"R43-8-20210206","first-page":"1185","article-title":"Luteinizing hormone-releasing hormone agonist and transferrin functionalizations enhance nanoparticle delivery in a novel bovine ex vivo eye model.","volume":"12","author":"Kompella","year":"2006","journal-title":"Mol Vis"},{"key":"R44-8-20210206","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5173(01)00760-8","article-title":"Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.","volume":"224","author":"De Campos","year":"2001","journal-title":"Int J Pharm"},{"key":"R45-8-20210206","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejps.2012.08.008","article-title":"Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye.","volume":"47","author":"Nagarwal","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"R46-8-20210206","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/10611860903450023","article-title":"Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.","volume":"18","author":"Wadhwa","year":"2010","journal-title":"J Drug Target"},{"key":"R47-8-20210206","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1208\/s12249-011-9675-1","article-title":"Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation.","volume":"12","author":"Bhagav","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"R48-8-20210206","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijpharm.2012.05.025","article-title":"Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.","volume":"434","author":"Kadam","year":"2012","journal-title":"Int J Pharm"},{"key":"R49-8-20210206","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/02652040802095250","article-title":"Sustained delivery of timolol maleate from poly(lactic-co-glycolic acid)poly(lactic acid) microspheres for over 3 months.","volume":"26","author":"Bertram","year":"2009","journal-title":"J Microencapsul"},{"key":"R50-8-20210206","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jbm.a.31147","article-title":"Fabrication and characterization of contact lenses bearing surface-immobilized layers of intact liposomes.","volume":"82","author":"Danion","year":"2007","journal-title":"J Biomed Mater Res A"},{"key":"R51-8-20210206","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2011.06.023","article-title":"Retinal ganglion cells survival in a glaucoma model by GDNFVit E PLGA microspheres prepared according to a novel microencapsulation procedure.","volume":"156","author":"Checa-Casalengua","year":"2011","journal-title":"J Control Release"},{"key":"R52-8-20210206","first-page":"1783","article-title":"Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.","volume":"13","author":"Jiang","year":"2007","journal-title":"Mol Vis"},{"key":"R53-8-20210206","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.biomaterials.2010.09.016","article-title":"Engineered superparamagnetic Mn0.5Zn0.5Fe2O4 nanoparticles as a heat shock protein induction agent for ocular neuroprotection in glaucoma.","volume":"32","author":"Jeun","year":"2011","journal-title":"Biomaterials"},{"key":"R54-8-20210206","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/jcbfm.1991.86","article-title":"Hyperthermia-induced neuronal protection against ischemic injury in gerbils.","volume":"11","author":"Kitagawa","year":"1991","journal-title":"J Cereb Blood Flow Metab"},{"key":"R55-8-20210206","doi-asserted-by":"crossref","first-page":"e16733","DOI":"10.1371\/journal.pone.0016733","article-title":"Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse.","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS One"},{"key":"R56-8-20210206","first-page":"639","article-title":"Glaucoma: thinking in new ways-a role for autonomous axonal self-destruction and other compartmentalised processes Prog Retin Eye R","volume":"24","author":"Whitmore","year":"2005","journal-title":"es"},{"key":"R57-8-20210206","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev.neuro.23.1.579","article-title":"The relationship between neuronal survival and regeneration.","volume":"23","author":"Goldberg","year":"2000","journal-title":"Annu Rev Neurosci"},{"key":"R59-8-20210206","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.preteyeres.2011.02.003","article-title":"Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models.","volume":"30","author":"Bernstein","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"R60-8-20210206","first-page":"1","article-title":"A novel rodent model of posterior ischemic optic neuropathy.","volume":"8","author":"Wang","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"R61-8-20210206","first-page":"2513","article-title":"Gene therapy for glaucoma: treating a multifaceted, chronic disease.","volume":"43","author":"Borras","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R62-8-20210206","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1167\/iovs.12-9483o","article-title":"Advances in glaucoma treatment and management: gene therapy.","volume":"53","author":"Borras","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R63-8-20210206","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1167\/iovs.10-6916","article-title":"AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects.","volume":"52","author":"Han","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R64-8-20210206","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue.","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"R65-8-20210206","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.biomaterials.2012.01.030","article-title":"The movement of self assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection.","volume":"33","author":"Koo","year":"2012","journal-title":"Biomaterials"},{"key":"R66-8-20210206","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2337\/db08-1327","article-title":"Nanoparticle mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage.","volume":"58","author":"Park","year":"2009","journal-title":"Diabetes"},{"key":"R67-8-20210206","doi-asserted-by":"crossref","first-page":"19042","DOI":"10.1073\/pnas.1019624108","article-title":"Nanoparticle-mediated signaling endosome localization regulates growth cone motility and neurite growth.","volume":"108","author":"Steketee","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R68-8-20210206","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pone.0000038","article-title":"Efficient nonviral ocular gene transfer with compacted DNA nanoparticles.","volume":"1","author":"Farjo","year":"2006","journal-title":"PLoS One"}],"container-title":["Current Opinion in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ICU.0b013e32835cfe92","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:23:14Z","timestamp":1786047794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00055735-201303000-00008"}},"subtitle":["little particles for a big disease"],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/icu.0b013e32835cfe92","relation":{},"ISSN":["1040-8738"],"issn-type":[{"value":"1040-8738","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}